The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

Author

JOHNSON, David W^{1 2} ; BROWN, Fiona G³ ; SCHOLLUM, John¹³ ; SURANYI, Michael G¹⁴ ; TAN, Seng H^{15 16 17} ; VOSS, David¹⁸ ; CLARKE, Margaret⁴ ; BOUDVILLE, Neil⁵ ; ELIAS, Tony J⁶ ; FOO, Marjorie W. Y⁷ ; JONES, Bernard⁸ ; KULKARNI, Hemant⁹ ; LANGHAM, Robyn^{10 11} ; RANGANATHAN, Dwarakanathan^{12 2}
[1] Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, Australia
[2] School of Medicine, University of Queensland, Brisbane, Australia
[3] Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
[4] Fresenius Medical Care, Sydney, New South Wales, Australia
[5] School of Medicine and Pharmacology, University of Western Australia, Perth, Australia
[6] Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia
[7] Singapore General Hospital, Singapore, Singapore
[8] John Hunter Hospital, Newcastle, New South Wales, Australia
[9] Fremantle Hospital, Fremantle, Western Australia, Australia
[10] St Vincent's Hospital, Melbourne, Australia
[11] University of Melbourne, Melbourne, Australia
[12] Royal Brisbane and Women's Hospital, B, Australia
[13] Dunedin Hospital, Dunedin, New Zealand
[14] Liverpool Hospital, Sydney, New South Wales, Australia
[15] Tan Tock Seng Hospital, Singapore, Singapore
[16] Changi General Hospital, Singapore, Singapore
[17] SH Tan Kidney and Medical Clinic, Mount Elizabeth Medical Centre, Singapore, Singapore
[18] Middlemore Hospital, Auckland, New Zealand
BalANZ Trial Investigators

Source

Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 12, pp 4445-4453, 9 p ; ref : 37 ref

CODEN

NDTREA

ISSN

0931-0509

Scientific domain

Anesthesia, intensive care; Graft, transplantation; Urology, nephrology

Publisher

Oxford University Press, Oxford

Publication country

United Kingdom

Document type

Article

Language

English

Author keyword

biocompatibility glucose degradation products outcomes peritoneal dialysis peritoneal equilibration test

Keyword (fr)

Biocompatibilité Dialyse péritonéale Epuration extrarénale Equilibration Etude comparative Glucose Hémodialyse Insuffisance rénale Produit dégradation Pronostic pH Pathologie de l'appareil urinaire Pathologie du rein

Keyword (en)

Biocompatibility Peritoneal dialysis Extrarenal dialysis Equilibration Comparative study Glucose Hemodialysis Renal failure Degradation product Prognosis pH Urinary system disease Kidney disease

Keyword (es)

Biocompatibilidad Diálisis peritoneal Depuración extrarrenal Equilibración Estudio comparativo Glucosa Hemodiálisis Insuficiencia renal Producto degradación Pronóstico pH Aparato urinario patología Riñón patología

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14A Nephropathies. Renovascular diseases. Renal failure / 002B14A01 Glomerulonephritis

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27B Intensive care medicine / 002B27B03 Emergency and intensive care: renal failure. Dialysis management

Discipline

Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Nephrology. Urinary tract diseases

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

26767024

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS